News | August 29, 2014

CardiacAssist Receives Health Canada Approval for Protek Duo Veno-Venous Cannula

August 29, 2014 — CardiacAssist announced it has received a Class 2 medical device license from Health Canada for its new Protek Duo veno-venous cannula. The Protek Duo is licensed for use as a single cannula for both venous drainage and reinfusion of blood via an internal jugular vein during extracorporeal life support procedures.

Approximately 18,000 people in Canada are diagnosed with acute respiratory distress syndrome (ARDS) every year. Despite receiving therapy with mechanical ventilation, which is widely considered the standard of care, almost half of those diagnosed with ARDS will die as a result of the disease. Veno-venous extracorporeal life support (VV ECLS) is an emerging therapy designed to provide a higher level of support by infusing oxygen directly into the blood using an oxygenator. In one large randomized, controlled clinical trial of 180 adult ARDS patients, the use of advanced VV ECLS therapy was shown to improve the rate of survival free of disability by 34 percent versus conventional management with mechanical ventilation.

The Protek Duo cannula is designed to address two major roadblocks that have previously kept VV ECLS therapy from becoming a new standard of care: the difficulty of initiating and maintaining a patient on VV ECLS support versus mechanical ventilation, and suboptimal gas exchange rates with currently available devices. Insertion of the Protek Duo cannula can be performed through a minimally invasive percutaneous procedure, and patient management is simplified by combining with the lightweight and compact TandemHeart pump, which can be placed directly on the patient. The TandemHeart platform recently received a Class 4 medical device license from Health Canada for up to 10 days of circulatory support and is designed to simplify patient ambulation and enable freedom of movement not possible with mechanical ventilation or any alternative ECLS device. Additionally, the Protek Duo cannula is designed for omnidirectional flow and can bypass the right ventricle of the heart by directing flow from the patient’s right atrium to the pulmonary artery, optimizing gas exchange and simultaneously reducing stress on the right side of the heart.

“The Canadian launch of the Protek Duo cannula is taking TandemHeart into new territory. We are now working on new innovations to help both heart and respiratory failure patients, with even more new products in the pipeline coming right behind Protek Duo. Our goal will be to keep respiratory patients moving while continuing our mission to advance the treatment of heart failure,” said John Marous, president and CEO of CardiacAssist.

For more information: www.cardiacassist.com

Related Content

Sponsored Content | Videos | Cardiovascular Ultrasound| July 19, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Pre-PCI Impella 2.5 Insertion Improves Survival in Left Main Coronary Artery Heart Attacks
News | Ventricular Assist Devices (VAD)| June 30, 2017
Abiomed Inc. announced the recent publication of a peer-reviewed retrospective study on hemodynamic support with the...
Italian Boy Becomes Youngest Patient Bridged to Transplant With SynCardia Total Artificial Heart

Andrei, 12, is the world’s youngest patient to be bridged to transplant with the SynCardia Total Artificial Heart. He is pictured after his heart transplant with his surgeon, Antonio Amodeo, M.D., at Bambino Gesù Children’s Hospital in Rome, Italy. Photo courtesy of Business Wire.

News | Congenital Heart| June 22, 2017
A 12-year-old boy at Bambino Gesù Children’s Hospital in Rome, Italy, has become the world’s youngest patient to be...
Abiomed Impella CP pVAD, third-generation CP
Technology | Hemodynamic Support Devices| June 12, 2017
June 12, 2017 — Abiomed Inc.
tandemLife Tandemheart priming tray cleared by FDA
Technology | Hemodynamic Support Devices| June 12, 2017
June 12, 2017 — TandemLife began its commercial launch of the TandemLife Priming Tray, a new product designed to simp
Sponsored Content | Videos | Cardiovascular Ultrasound| May 26, 2017
This video, provided in partnership with the American Society of Echocardiography (ASE), is titled "Intraoperative Tr
Impella CP study to investigate door to left ventricular unloading time
News | May 09, 2017
May 9, 2017 — The first patient has been enrolled in the U.S.
Heartware HVAD recall for its ventricular assist device from Medtronic
Feature | Ventricular Assist Devices (VAD)| May 05, 2017
May 5, 2017 — Medtronic Mechanical Circulatory Support is expanding its recall of its HeartWare Ventricular Assist De
the Impella pVAD improves survival, mortality in AMI heart attack with cardiogenic shock

Early use of the Impella percutaneous ventricular assist device prior to angioplasty may significantly improve survival for patients in cardiogenic shock.

Feature | Hemodynamic Support Devices| April 28, 2017 | Dave Fornell
Recent clinical study data presented at the American College of Cardiology (ACC) 2017 meeting show new treatment prot
Sponsored Content | Videos | Ventricular Assist Devices (VAD)| April 14, 2017
A discussion with William O'Neill, M.D., FACC, FSCAI, medical director of the Center for Structural Heart Disease at
Overlay Init